INTERNATIONAL MEDICAL CENTER (IMC)
The capital of the International Medical Center Company (IMC) (a closed joint stock Company) is SAR 750 million, and the contribution of Fitaihi Holding Group is estimated at 19.25% of the total capital of IMC, and the transfer of the Company was approved according to the Minister of Commerce and Industry Decision (Ministerial Decree) No. (Q/99) on 08/04/1437H, from (Limited Liability Company) to (Closed joint stock Company).
In order to fulfill its mission to follow the best international medical standards in treatment, the hospital obtained the Joint Commission International (JCI) accreditation for assessing the quality of health services for the first time in 2008, with the highest success rate in the region, for the second time in 2011, for the third time in January 2014, then for the fourth time in February 2017G, and for a period of 3 years until 2020. The establishment was assessed for accreditation for 5th time in February 2020 for a period of 3 years extending up to 2023.
The IMC also obtained the Australian Council for Healthcare Standards International (ACHSI) accreditation in October 2014 for a period of 4 years, and the re-assessment took place in December 2018, and the renewal was for a period of 4 years until 2023.
At the local level, the IMC was keen to obtain the accreditation of the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI), which it successfully obtained for a period extended from November 2017 to November 2020, and the facility was assessed for accreditation in September 2020, for a period of 3 years extends to 2023.
In 2014, a cooperation was made between the IMC and the American College of Surgeons to monitor and analyze the results of surgical operations, As part of the IMC’s journey and its aspiration to improve the services provided to its patients, it has obtained the accreditation certificate from the American Association of Blood Bank (AABB) in 2018, and then obtained the accreditation certificate in February 2020, which extends for 2 years until 2022.
The IMC won the King Abdulaziz Quality Award for the category of private health facilities at the silver level for the year 2020, and IMC was the only private hospital to win this competition. The King Abdulaziz Quality Award is the main award for institutional excellence at the level of KSA and for all sectors. Therefore, participation in the award race is one of the most important indicators of the establishments’ leaders ’adoption of quality and excellence and providing products and services that meet and exceed the beneficiaries’ aspirations.
Dr. Mohammed Ahmed Hassan Fitaihi and Mr. Yasser Yehia Abdelhamid (CEO) represent Fitaihi Holding Group on the Board of Directors of the IMC, in order to reinforce the strategy of Fitaihi Holding Group in focusing on its investment in the medical sector.
On 30/09/2021, the Board of Directors of the IMC issued a resolution to take the necessary measures to transform the IMC into a public joint-stock company listed in the main market.